Literature DB >> 16030465

Pessary treatment of pelvic relaxation: factors affecting successful fitting and continued use.

John N Nguyen1, Chris R Jones.   

Abstract

OBJECTIVES: The aims of this study were to determine predictors of successful pessary fitting and continued pessary use in patients with pelvic relaxation.
DESIGN: Retrospective observational study. SETTING AND
SUBJECTS: The medical records of 130 consecutive patients evaluated for pessary treatment of pelvic relaxation by a single specially trained nurse practitioner (CRJ) at Kaiser Foundation Hospital, Harbor City, Calif, between May 1, 1997, and June 30, 2002, were retrospectively reviewed. INSTRUMENTS: Voiding diaries, data collection sheet, and questionnaires.
METHODS: The medical records of the 130 patients were retrospectively reviewed, and data were recorded on data collection sheets. Patients using pessaries completed a questionnaire to assess treatment effectiveness.
RESULTS: Coexisting stress urinary incontinence and previous prolapse and cystocele/rectocele repairs were each found to be independent predictors of unsuccessful pessary fitting. Fifty percent of successfully fitted patients had discontinued pessary use by 24 months. Current pessary users were more likely to have undergone prior pelvic reconstructive surgery (37% vs 13%, P = .02), less likely to require a space-filling pessary (13% vs 37%, P = .03), and more likely to recommend pessary to their friends or family (87% vs 50%, P = .007) compared to patients who discontinued pessary use.
CONCLUSIONS: Prior pelvic reconstructive surgery is associated with an increased risk of unsuccessful pessary fitting; however, those patients who are successfully fitted tend to continue pessary use.

Entities:  

Mesh:

Year:  2005        PMID: 16030465     DOI: 10.1097/00152192-200507000-00010

Source DB:  PubMed          Journal:  J Wound Ostomy Continence Nurs        ISSN: 1071-5754            Impact factor:   1.741


  8 in total

1.  Successful use of ring pessary with support for advanced pelvic organ prolapse.

Authors:  Jing Ding; Chun Chen; Xiao-Chen Song; Lei Zhang; Mou Deng; Lan Zhu
Journal:  Int Urogynecol J       Date:  2015-05-16       Impact factor: 2.894

2.  Vaginal Pessaries for Pelvic Organ Prolapse or Stress Urinary Incontinence: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-05-06

3.  What is known from the existing literature about self-management of pessaries for pelvic organ prolapse? A scoping review protocol.

Authors:  Lucy Dwyer; Dawn Dowding; R Kearney
Journal:  BMJ Open       Date:  2022-01-11       Impact factor: 2.692

Review 4.  What is known from the existing literature about self-management of pessaries for pelvic organ prolapse? A scoping review.

Authors:  Lucy Dwyer; Dawn Dowding; R Kearney
Journal:  BMJ Open       Date:  2022-07-18       Impact factor: 3.006

Review 5.  What are the barriers and facilitators to self-management of chronic conditions reported by women? A systematic review.

Authors:  Lucy Dwyer; Dawn Dowding; Rohna Kearney
Journal:  BMJ Open       Date:  2022-07-20       Impact factor: 3.006

6.  Theoretical and practical development of the TOPSY self-management intervention for women who use a vaginal pessary for pelvic organ prolapse.

Authors:  Lucy Dwyer; Carol Bugge; Suzanne Hagen; Kirsteen Goodman; Wael Agur; Melanie Dembinsky; Margaret Graham; Karen Guerrero; Christine Hemming; Aethele Khunda; Doreen McClurg; Lynn Melone; Ranee Thakar; Rohna Kearney
Journal:  Trials       Date:  2022-09-05       Impact factor: 2.728

7.  Incontinence pessaries: size, POPQ measures, and successful fitting.

Authors:  Charles W Nager; Holly E Richter; Ingrid Nygaard; Marie Fidela Paraiso; Jennifer M Wu; Kimberly Kenton; Shanna D Atnip; Cathie Spino
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-06-16

8.  Predictors of unsuccessful pessary fitting in women with prolapse: a cross-sectional study in general practice.

Authors:  Chantal M C R Panman; Marian Wiegersma; Boudewijn J Kollen; Huibert Burger; Marjolein Y Berger; Janny H Dekker
Journal:  Int Urogynecol J       Date:  2016-08-15       Impact factor: 2.894

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.